These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 36380821)
1. Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital Are Maintained 4 Years after Initiation. Khan JH; Barkin MS; Stanton J; Khan A; Stanten RD J Extra Corpor Technol; 2022 Mar; 54(1):35-41. PubMed ID: 36380821 [TBL] [Abstract][Full Text] [Related]
2. Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital. Khan JH; Green EA; Chang J; Ayala AM; Barkin MS; Reinys EE; Stanton J; Stanten RD J Extra Corpor Technol; 2017 Dec; 49(4):273-282. PubMed ID: 29302118 [TBL] [Abstract][Full Text] [Related]
3. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery. Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152 [TBL] [Abstract][Full Text] [Related]
4. Less is more: We are administering too much protamine in cardiac surgery. De Simone F; Nardelli P; Licheri M; Frau G; Redaelli MB; Monaco F; Zangrillo A; Landoni G Ann Card Anaesth; 2021; 24(2):178-182. PubMed ID: 33884973 [TBL] [Abstract][Full Text] [Related]
5. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568 [TBL] [Abstract][Full Text] [Related]
7. Protamine dosing and its impact in cardiac surgery transfusion practice-A retrospective bi-institutional analysis. Mondal S; Abuelkasem E; Vesselinov R; Henderson R; Choi S; Mousa A; Zaza KJ; Tanaka KA Transfusion; 2024 Mar; 64(3):467-474. PubMed ID: 38264767 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery. Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519 [TBL] [Abstract][Full Text] [Related]
9. A change in anticoagulation monitoring improves safety, reduces transfusion, and reduces costs in infants on cardiopulmonary bypass. Machovec KA; Jooste EH; Walczak RJ; Homi HM; Jaquiss RD; Lodge AJ; Ames WA Paediatr Anaesth; 2015 Jun; 25(6):580-6. PubMed ID: 25530420 [TBL] [Abstract][Full Text] [Related]
10. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988 [TBL] [Abstract][Full Text] [Related]
11. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass. Miles LF; Marchiori P; Falter F Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026 [TBL] [Abstract][Full Text] [Related]
12. Can the Minimum Protamine Dose to Neutralize Heparin at the Completion of Cardiopulmonary Bypass be Significantly Lower than the Conventional Practice? Lee MH; Riley W; Shann KG J Extra Corpor Technol; 2021 Sep; 53(3):170-176. PubMed ID: 34658407 [TBL] [Abstract][Full Text] [Related]
18. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial. Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705 [TBL] [Abstract][Full Text] [Related]
19. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. Levin AI; Heine AM; Coetzee JF; Coetzee A J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364 [TBL] [Abstract][Full Text] [Related]
20. A 0.6-protamine/heparin ratio in cardiac surgery is associated with decreased transfusion of blood products. Goedhart ALM; Gerritse BM; Rettig TCD; van Geldorp MWA; Bramer S; van der Meer NJM; Boonman-de Winter LJ; Scohy TV Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):391-397. PubMed ID: 32620960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]